Press Release

International Prize

Balzan Prize goes to German lung researchers

This year’s internationally renowned Balzan Prize for “Pathophysiology of respiration: from basic research to the bedside” goes to four researches of DZL, the German Center for Lung Research (Deutschen Zentrums für Lungenforschung). Amongst the winners is Prof. Erika von Mutius, Head of the Institute for Institute for Asthma and Allergy Prevention at Helmholtz Zentrum München as well as DZL Board Member and Director of the DZL Munich Site (CPC-M). The prize is 750,000 Swiss Francs (around 680,000 Euros).

Image: Prof. Erika von Mutius, Head of the Institute for Asthma and Allergy Prevention (IAP) at Helmholtz Zentrum München © Helmholtz Zentrum München

Together with DZL Chairman Prof. Werner Seeger and the other DZL Executive Board members Prof. Klaus Rabe and Prof. Tobias Welte, Mutius received the prize for their outstanding performance in lung research. With innovative research, the DZL team is developing new therapies to improve the quality of life for patients with lung diseases. The DZL is also creating new paths for future generations of scientists. Von Mutius commented: “To be awarded the Balzan Prize is a very special honor for me and at the same time all the scientists at the German Center for Lung Research. I am very pleased that our efforts and successes in researching and combating lung diseases now have received such high recognition and appreciation.”

The award ceremony will take place on November 15 in Bern, Switzerland.

Science competing internationally

The international Balzan Prize Foundation honors outstanding researchers, scientist or artists every year with four different prizes. The award disciplines change annually – from humanities, social sciences and art to physics, mathematics, nature sciences and medicine. The aim of the Balzan Prizes is to promote culture, science, and remarkable initiatives for humanity, peace and fraternity regardless of nationality, race or religion. The prize is awarded in an international competition with a global call for papers supervised by a committee of highly qualified experts.

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus, allergies and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,500 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 19 scientific-technical and medical-biological research centers with a total of about 37,000 staff members.